Search for: "Kahn v. Price" Results 41 - 60 of 60
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Aug 2015, 5:29 pm by Kevin LaCroix
However, in the 2014 Delaware Supreme Court case Kahn v. [read post]
24 Nov 2009, 8:31 pm
Kahn by 11/4, overruling longstanding antitrust precedent on vertical price maintenance.) [read post]
5 Oct 2010, 4:05 pm
The IPO's Economics, Research and Evidence Team consists of Tony Clayton, Benjamin Mitra-Kahn, David Humphries, Grace Edgar, Peter Evans, Rose Geeson and Tony Creaton, at least a couple of whom seem to be quite Kat-friendly.   [read post]
16 Jan 2020, 3:20 pm by Francis Pileggi
  The High Court determined that the requirement was not satisfied based on the facts of the instant case because the “economic bargaining took place prior to the date” when the protections announced in the Kahn v. [read post]
15 Mar 2015, 9:01 pm by Ronald D. Rotunda
Berger, Kahn, Shafton, Moss, Figler, Simon & Gladstone, 131 Cal. [read post]
26 Aug 2016, 6:21 am
He connected with individuals around the world whom he knew only by screen names such as `Moody Blues’ or “Aly Kahn,” or by email addresses. [read post]
27 May 2009, 12:58 am
But in a surprise move Tuesday, attorneys Theodore Olson and David Boies, who opposed each other in Bush v. [read post]
18 Jun 2019, 6:42 am by Francis Pileggi
Apr. 16, 2019), the Court reversed the Court of Chancery’s holding that “unaffected market price” was the fair value on the date of the merger. [read post]
27 Mar 2019, 1:00 am by Thaddeus Mason Pope, JD, PhD
Pharmaceutical Pricing Jaime King, University of California Hastings College of the Law, The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs Marc Rodwin, Suffolk University Law School, Controlling Pharmaceutical Prices: What the U.S. [read post]
27 Apr 2017, 1:30 am by Thaddeus Mason Pope, JD, PhD
Kline School of Law, Taming Pharma with Benefit CorporationsDmitry Karshtedt, The George Washington University Law School, Regulating ‘Evergreening’: The FDA's Role in the Creation of Balanced Rights for Pharmaceutical ImprovementsMichael Sinha, Brigham and Women's Hospital and Harvard Medical School, Legal Approaches to Ensuring Timely Generic Drug AvailabilityRebecca Wolitz, Stanford Law School, Patents, Preemption, and Price-Gouging Teaching Session 1G – Room… [read post]